Collin G B, Marshall J D, Cardon L R, Nishina P M
Jackson Laboratory, Bar Harbor, ME 04609-1500, USA.
Hum Mol Genet. 1997 Feb;6(2):213-9. doi: 10.1093/hmg/6.2.213.
Alström syndrome is a rare autosomal recessive disorder characterized by pigmentary retinal degeneration, sensorineural hearing loss, childhood obesity, non-insulin-dependent diabetes mellitus, hyperlipidemia and chronic nephropathy. Features occasionally observed include acanthosis nigricans, hypogonadism, hypothyroidism, alopecia, short stature and cardiomyopathy. We report here the results of a linkage study in a large French Acadian kindred, as a first step in identifying the molecular basis of Alström syndrome. Evidence of a founder effect made if feasible to use a homozygosity mapping strategy to identify the chromosomal location of the Alström gene. In a genome-wide screen, haplotype sharing for a region on chromosome 2 was observed in all affected individuals. Two point linkage analysis resulted in a maximum lod score of 3.84 (theta = 0.00) for marker D2S292. By testing additional markers, the disease gene was localized to a 14.9 cM region on chromosome 2p.
阿尔斯特伦综合征是一种罕见的常染色体隐性疾病,其特征为色素性视网膜变性、感音神经性听力丧失、儿童期肥胖、非胰岛素依赖型糖尿病、高脂血症和慢性肾病。偶尔观察到的特征包括黑棘皮病、性腺功能减退、甲状腺功能减退、脱发、身材矮小和心肌病。我们在此报告一项针对一个大型法裔阿卡迪亚家族的连锁研究结果,作为确定阿尔斯特伦综合征分子基础的第一步。奠基者效应的证据使得使用纯合性定位策略来确定阿尔斯特伦基因的染色体位置成为可能。在全基因组筛查中,在所有受影响个体中均观察到2号染色体上一个区域的单倍型共享。两点连锁分析得出标记D2S292的最大对数优势得分为3.84(θ = 0.00)。通过检测其他标记,疾病基因被定位到2号染色体短臂上一个14.9厘摩的区域。